Exchange: NASDAQ·Updated 07:47 PM EDT
MLYS logo

MLYS Mineralys Therapeutics Inc

$28.21
$0.06
(0.21%)
Today
Closed $28.21
$0.41
(1.45%)
After Hours
Reported EarningsAug 11
Mkt Cap$2.49B
Vol643,518.00

About MLYS

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
77

Extremely Bullish Sentiment

How do you feel about MLYS?

Advertisement|Remove ads.